Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
About this item
Full title
Author / Creator
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Women with osteoporosis who had been taking alendronate for at least 1 year were randomly assigned to continued therapy with alendronate alone or with daily or cyclic parathyroid hormone (1–34) for 15 months. Indexes of bone formation rose quickly in both parathyroid hormone groups but declined during cycles without parathyroid hormone, increasing...
Alternative Titles
Full title
Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_17370607
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_17370607
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa050157
